N4 Pharma Plc (FRA:0GO)

N4 Pharma Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.73	0.63	1.03	1.92	1.78	3.56
Cash & Short-Term Investments	1.73	0.63	1.03	1.92	1.78	3.56
Cash Growth	43.37%	-39.05%	-46.49%	7.60%	-49.83%	268.17%
Other Receivables	-	0.13	0.18	0.21	0.55	0.25
Receivables	0.12	0.13	0.18	0.21	0.55	0.25
Prepaid Expenses	-	0.02	0.01	0.04	0.01	0.02
Total Current Assets	1.85	0.78	1.21	2.17	2.34	3.83
Goodwill	-	-	0.06	-	-	-
Total Assets	1.85	0.78	1.28	2.17	2.34	3.83
Accounts Payable	0.03	0.02	0.02	0.04	0.18	0.12
Accrued Expenses	0.05	0.1	0.06	0.04	0.03	0.03
Other Current Liabilities	-	0.01	0.01	0	0	0.03
Total Current Liabilities	0.08	0.12	0.08	0.08	0.21	0.17
Total Liabilities	0.08	0.12	0.08	0.08	0.21	0.17
Common Stock	3.33	1.58	1.08	0.94	0.72	0.72
Additional Paid-In Capital	14.74	14.94	14.87	14.7	13.95	13.95
Retained Earnings	-10.9	-10.4	-9.34	-8.06	-7.03	-5.49
Comprehensive Income & Other	-5.4	-5.47	-5.48	-5.48	-5.51	-5.52
Total Common Equity	1.77	0.65	1.13	2.09	2.13	3.66
Minority Interest	0	0	0.07	-	-	-
Shareholders' Equity	1.77	0.65	1.19	2.09	2.13	3.66
Total Liabilities & Equity	1.85	0.78	1.28	2.17	2.34	3.83
Net Cash (Debt)	1.73	0.63	1.03	1.92	1.78	3.56
Net Cash Growth	43.37%	-39.05%	-46.49%	7.60%	-49.83%	274.37%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.01	0.03
Filing Date Shares Outstanding	576.55	394.78	268.78	233.78	181.08	181.08
Total Common Shares Outstanding	576.55	394.78	268.78	233.78	181.08	181.08
Working Capital	1.77	0.65	1.13	2.09	2.13	3.66
Book Value Per Share	0.00	0.00	0.00	0.01	0.01	0.02
Tangible Book Value	1.77	0.65	1.07	2.09	2.13	3.66
Tangible Book Value Per Share	0.00	0.00	0.00	0.01	0.01	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.